FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/045093 [Registered on: 30/08/2022] Trial Registered Prospectively
Last Modified On: 28/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Behavioral 
Study Design  Other 
Public Title of Study   To Study the effect of Lifestyle modification with special reference to aharvidhividhan and Bhojanottarvidhi vidhan( Rules of dietic)on Agnimandya 
Scientific Title of Study   A Randomized Clinical Trial to Study the Effect of Lifestyle Modification with special reference to Aharvidhividhan and Bhojanottar vidhividhan on Agnimandya 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pallavi Narendra Agarkar 
Designation  PG Scholar 
Affiliation  Vidarbha Ayurved mahavidyalaya  
Address  vidarbha Ayurved Mahavidyalaya, Chatri Talao Road,Near Farsi Stop Amravati

Amravati
MAHARASHTRA
444601
India 
Phone  9834645280  
Fax    
Email  drpallaviagarkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sanjay K Chopkar 
Designation  Guide and HOD Department of Swasthvritta and Yoga 
Affiliation  Vidarbha Ayurved mahavidyalaya  
Address  vidarbha Ayurved Mahavidyalaya, Chatri Talao Road,Near Farsi Stop Amravati

Amravati
MAHARASHTRA
444601
India 
Phone  9423105104  
Fax    
Email  skchopkar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pallavi Narendra Agarkar 
Designation  PG Scholar 
Affiliation  Vidarbha Ayurved mahavidyalaya  
Address  vidarbha Ayurved Mahavidyalaya, Chatri Talao Road,Near Farsi Stop Amravati

Amravati
MAHARASHTRA
444601
India 
Phone  9834645280  
Fax    
Email  drpallaviagarkar@gmail.com  
 
Source of Monetary or Material Support  
Vidarbha Ayurved Mahavidyalaya Amravati 
 
Primary Sponsor  
Name  Vidarbha Ayurved Mahavidyalaya Amravati 
Address  Chatri Talao Road,Near Farsi Stop, Amravati 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pallavi Narendra Agrakar  Vidarbha Ayurved Mahavidyalaya and Hospital Amravati  OPD no 12, Department of Swastha vritta and Yoga Vidarbha Ayurved Mahavidyala Hospital Chatri Talao road, Near Farsi Stop Amravati
Amravati
MAHARASHTRA 
9834645280

drpallaviagarkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
S.H.V.P.M. Vidarbha Ayurved mahavidyalaya Amravati  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K00-K95||Diseases of the digestive system. Ayurveda Condition: Agnimandya, (2) ICD-10 Condition:K929||Disease of digestive system, unspecified. Ayurveda Condition: MANDAGNIH/ AGNISADA, (3) ICD-10 Condition:K929||Disease of digestive system, unspecified. Ayurveda Condition: Agnimandya,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Trikatu Churna, Reference: Bhaishajya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 1 Months, anupAna/sahapAna: Yes(details: Koshna Jala), Additional Information: -
2Intervention ArmLifestyle--Dinacarya: , Ritucarya: , Acara Rasayana:, Other:Aharvidhividhan and bhojanottar vidhi vidhan,, Pathya/Apathya:yes, Pathya:Follow : Aharvidhividhan and bhojanottar vidhi vidhan,, Apathya:Avoiding Aharvidhividhan and bhojanottar vidhi vidhan,
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  subject having signs and symptoms of agnimandya
like
avipak,
prasek,
kshudhamandya,
Shirogaurav,
Amashay pradeshi gaurav,
Shirogaurav,
Antrakujan,
Pravahan,
malbaddhata,
Jaran shakti,
Abhyavharan Shakti,
Mala samata
patient having any 2 or more symptoms among these.
having symptoms not more than 2 months. 
 
ExclusionCriteria 
Details  patient age less than 20 and more than 60 years,
patients diagnosed with any pathology of GIT such as Cancer of GIT, Liver, pancreas, gall bladder, peptic and gastric ulcer, gastro-esophageal reflux, gall stone, renal failure, hepatitis, tuberculosis will be excluded.
pregnant and lactating mother,
people not ready to give written consent, and
not ready to change their lifestyle due to occupation or duties.
Agnimandya caused due to medicine intake. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Complete Remission from Agnimandya 76-100%
Marked Improvement in Agnimandya 51-75%
mild improvement in Agnimandya 25-50% 
0th day
3rd Day
7th Day
14th Day
21st Day
28th Day
35th Day
42nd Day
49th Day
56th Day
63th Day
70th Day 
 
Secondary Outcome  
Outcome  TimePoints 
Remission in symptoms of anaemia
Remission in symptoms of obesity
weight gain in thin built persons (Karshya) 
0th day
14th day
35th day
49th day
70th day 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   31/08/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Randomized clinical trial will be conducted to study the effect of Lifestyle modification with special reference to Aharvidhividhan and Bhojanottar vidhividhan on Agnimandya. Trial will be conducted in our Institute . total 120 patients with Inclusive Criteria having Signs and symptoms of Agnimandya  will be selected and will be divided in two groups. one group will be advised Lifestyle modifications i.e Aharvidhividhan and Bhojanottar vidhividhan  and other group will be observed only. and result will be compared. Primary outcome will be about Evaluation of Lifestyle distrubance  and the Secondary Outcome will be about assessment criteria of effect of therapy. and results will be noted 
Close